VC firm
AllerFund
Also known as AllerFund Yumi SPV, AllerFund Yumi SPV, LLC, AllerFund Yumi SPV2, AllerFund Yumi SPV2, LLC
- Investor type
- VC
- Investing status
- Activeas of 2026-09-21Source (opens in a new tab)
- Headquarters
- New York, NY, United States
- Assets under management
- $19MForm ADV private fund GAV, as of 2026-03-18Source (opens in a new tab)
- Funds
- 5
- Legal name
- Allerfund Ventures, LLC
Claim, correct or request removal
Record updated 30 September 2026
About
AllerFund is the first venture capital firm dedicated to driving social impact for the food allergy community.
Investment approach
- Thesis
- Accelerate development of new treatments, diagnostics and products for children and adults with, or at risk of developing, food allergiesSource (opens in a new tab)
- Eligibility
- We want to hear from you if you have made a discovery or created a product that will improve the lives of those with food allergies, or are interested in learning more about us.
- Investing status notes
- We want to hear from you if you have made a discovery or created a product that will improve the lives of those with food allergies, or are interested in learning more about us.
Funds
- AllerFund Yumi SPV2, LLC
- $1MVintage 2023, SPV, SEC amount sold
- AllerFund Yumi SPV, LLC
- $775KVintage 2022, SPV, SEC amount sold
- ALLERFUND I, L.P.
- Main fund
- ALLERFUND YUMI SPV, LLC
- SPV
- ALLERFUND YUMI SPV2, LLC
- Main fund
SEC registration
- Registered adviser
- ALLERFUND VENTURES, LLC
- CRD number
- 336235 (opens in a new tab)
- SEC file number
- 802-134717
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $19Mas of 2026-03-18
- Private funds reported
- 3
- Principal office
- NEW YORK, NY, United States
- SEC CIK
- 1951884, 2007385
Loading relationship preview